Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 2/20 | 0.62 |
| ▸ | LTA4H | P09960 | 3/20 | 0.60 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | NPC1 | O15118 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | GAA | P10253 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | RAB9A | P51151 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | CNR2 | P34972 | 2/20 | 0.49 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.49 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.48 |
| ▸ | APP | P05067 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31490079 | 0.94 | NR5A1 (0.70) | ADRB2LTA4HNR5A1MEN1NPC1 | |
| SCHEMBL26548854 | 0.94 | NR5A1 (0.70) | ADRB2LTA4HNR5A1MEN1NPC1 | |
| SCHEMBL3302299 | 0.94 | NR5A1 (0.70) | ADRB2LTA4HNR5A1MEN1NPC1 | |
| SCHEMBL7054543 | 0.94 | NR5A1 (0.70) | ADRB2LTA4HNR5A1MEN1NPC1 | |
| SCHEMBL11346377 | 0.94 | NR5A1 (0.70) | ADRB2LTA4HNR5A1MEN1NPC1 | |
| SCHEMBL1050330 | 0.92 | LTA4H (0.60) | ADRB2LTA4HNR5A1MEN1NPC1 | |
| SCHEMBL6244383 | 0.90 | LTA4H (0.58) | ADRB2LTA4HNR5A1MEN1NPC1 | |
| SCHEMBL107216 | 0.89 | ADRB2 (0.62) | ADRB2LTA4HNR5A1MEN1NPC1 | |
| SCHEMBL339126 | 0.88 | MEN1 (0.65) | ADRB2LTA4HNR5A1MEN1NPC1 | |
| SCHEMBL15387356 | 0.87 | ADRB2 (0.61) | ADRB2LTA4HNR5A1MEN1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4283478-A | COMPRISING A SILVER HALIDE LAYER AND A LAYER OF POSITIVE WORKING LIGHT SENSITIVE RESIN | FUJI PHOTO FILM CO., LTD. (JP) | 1981-08-11 | — | — | US | claimed |
| EP-2318477-B1 | ADDITIVES TO PREVENT DEGRADATION OF CYCLIC ALKENE DERIVATIVES | FUJIFILM ELECTRONIC MAT USA INC (US) | 2019-06-05 | — | — | EP | disclosed |
| US-8252704-B2 | Additives to prevent degradation of cyclic alkene derivatives | FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. (US) | 2012-08-28 | — | — | US | disclosed |
| US-20110259242-A1 | Additives to Prevent Degradation of Cyclic Alkene Derivatives | FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. (US) | 2011-10-27 | — | — | US | disclosed |
| US-7985350-B2 | Additives to prevent degradation of cyclic alkene derivatives | FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. (US) | 2011-07-26 | — | — | US | disclosed |
| EP-2318477-A1 | ADDITIVES TO PREVENT DEGRADATION OF CYCLIC ALKENE DERIVATIVES | FujiFilm Electronic Materials USA, Inc. (US) | 2011-05-11 | — | — | EP | disclosed |
| US-20110091651-A1 | Additives to Prevent Degradation of Cyclic Alkene Derivatives | FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. (US) | 2011-04-21 | — | — | US | disclosed |
| US-7871536-B2 | Additives to prevent degradation of cyclic alkene derivatives | FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. (US) | 2011-01-18 | — | — | US | disclosed |
| WO-2010005937-A1 | ADDITIVES TO PREVENT DEGRADATION OF CYCLIC ALKENE DERIVATIVES | FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. (US) | 2010-01-14 | — | — | WO | disclosed |
| US-20090291210-A1 | Additives to Prevent Degradation of Cyclic Alkene Derivatives | FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. (US) | 2009-11-26 | — | — | US | disclosed |
| EP-0598241-B1 | Lithographic printing material | FUJI PHOTO FILM CO LTD (JP) | 1998-02-04 | — | — | EP | disclosed |
| US-5387483-A | Developer containing silver halide solvent and hydroquinone; has pH up to 11.8 | FUJI PHOTO FILM CO., LTD. (JP) | 1995-02-07 | — | — | US | disclosed |
| EP-0610936-A2 | Lithographic printing material | FUJI PHOTO FILM CO., LTD. (JP) | 1994-08-17 | — | — | EP | disclosed |
| EP-0608777-A1 | Processing of lithographic printing material | FUJI PHOTO FILM CO., LTD. (JP) | 1994-08-03 | — | — | EP | disclosed |
| EP-0601600-A2 | Processing of lithographic printing material and developer used therein | FUJI PHOTO FILM CO., LTD. (JP) | 1994-06-15 | — | — | EP | disclosed |
| EP-0598241-A1 | Lithographic printing material | FUJI PHOTO FILM CO., LTD. (JP) | 1994-05-25 | — | — | EP | disclosed |
| US-4558129-A | Benzodioxanyl-hydroxyethylene-piperazinyl acetanilides which effect calcium entry and β-blockade | SYNTEX (U.S.A.) INC. (US) | 1985-12-10 | — | — | US | disclosed |
| US-4499100-A | CARDIOUVASCULAR DISORDERS | SYNTEX (U.S.A.) INC. (US) | 1985-02-12 | — | — | US | disclosed |
| US-4283478-A | COMPRISING A SILVER HALIDE LAYER AND A LAYER OF POSITIVE WORKING LIGHT SENSITIVE RESIN | FUJI PHOTO FILM CO., LTD. (JP) | 1981-08-11 | — | — | US | disclosed |
| US-4212645-A | Hair dyeing composition containing an aryldiamine and a substituted catechol | LEVER BROTHERS COMPANY (US) | 1980-07-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110259242-A1 | Additives to Prevent Degradation of Cyclic Alkene Derivatives | GPX4, GPX1, NFE2L2 | ADRB2 966/4885LTA4H 643/4885NR5A1 666/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.